ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,446.00
      2.17%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      82.765
      0.00%
      Bitcoin
      63,234.92
      -1.03%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Redhill Biopharma Ltd (RDHL)

      7. Redhill Biopharma Ltd (RDHL) News

      RDHL

      Redhill Biopharma (RDHL)

      Redhill Biopharma Ltd
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:RDHL
      DateTimeSourceHeadlineSymbolCompany
      04/24/20247:00AMPR Newswire (US)RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 StudyNASDAQ:RDHLRedhill Biopharma Ltd
      04/08/20249:23AMPR Newswire (US)RedHill Biopharma Announces Full-Year 2023 Results and Operational HighlightsNASDAQ:RDHLRedhill Biopharma Ltd
      04/02/20247:00AMPR Newswire (US)RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market PriceNASDAQ:RDHLRedhill Biopharma Ltd
      03/11/20247:01AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
      03/11/20247:00AMPR Newswire (US)RedHill Announces New USPTO Patent Covering Talicia® Through 2034NASDAQ:RDHLRedhill Biopharma Ltd
      03/05/20247:01AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
      03/05/20247:00AMPR Newswire (US)RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures ProgramsNASDAQ:RDHLRedhill Biopharma Ltd
      02/20/20244:05PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
      02/20/20247:01AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
      02/20/20247:00AMPR Newswire (US)RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New PublicationNASDAQ:RDHLRedhill Biopharma Ltd
      02/16/20248:54AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:RDHLRedhill Biopharma Ltd
      02/16/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RDHLRedhill Biopharma Ltd
      02/13/20244:05PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
      02/05/20248:00AMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:RDHLRedhill Biopharma Ltd
      02/02/20244:10PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:RDHLRedhill Biopharma Ltd
      02/01/202410:22AMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:RDHLRedhill Biopharma Ltd
      01/26/202412:50PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
      01/26/202412:46PMPR Newswire (US)RedHill Biopharma Announces Closing of $8 Million Registered Direct OfferingNASDAQ:RDHLRedhill Biopharma Ltd
      01/26/20249:31AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
      01/26/20249:29AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RDHLRedhill Biopharma Ltd
      01/25/20249:09AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
      01/25/20249:05AMPR Newswire (US)RedHill Biopharma Announces $8 Million Registered Direct OfferingNASDAQ:RDHLRedhill Biopharma Ltd
      01/25/20246:02AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
      01/25/20246:00AMPR Newswire (US)RedHill Announces New USPTO Patent Grant for Talicia® for H. pylori Treatment Through 2042NASDAQ:RDHLRedhill Biopharma Ltd
      12/20/20238:45AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
      12/20/20238:45AMPR Newswire (US)RedHill and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against EbolaNASDAQ:RDHLRedhill Biopharma Ltd
      12/12/20237:03AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
      12/12/20237:00AMPR Newswire (US)RedHill Biopharma Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:RDHLRedhill Biopharma Ltd
      12/06/20237:01AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
      12/04/20237:03AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
       Showing the most relevant articles for your search:NASDAQ:RDHL